Yaron Weber
Stock Analyst at TD Cowen
(2.20)
# 2,803
Out of 5,154 analysts
9
Total ratings
55.56%
Success rate
8.53%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yaron Weber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASND Ascendis Pharma | Reiterates: Buy | $325 | $237.35 | +36.93% | 1 | Jan 7, 2026 | |
| ZYME Zymeworks | Initiates: Buy | n/a | $24.80 | - | 1 | May 20, 2025 | |
| AMGN Amgen | Maintains: Buy | $381 → $383 | $367.60 | +4.19% | 5 | Oct 21, 2024 | |
| NUVB Nuvation Bio | Initiates: Outperform | n/a | $4.57 | - | 1 | Mar 8, 2021 | |
| REGN Regeneron Pharmaceuticals | Maintains: Outperform | $684 → $565 | $764.93 | -26.14% | 1 | Feb 8, 2021 |
Ascendis Pharma
Jan 7, 2026
Reiterates: Buy
Price Target: $325
Current: $237.35
Upside: +36.93%
Zymeworks
May 20, 2025
Initiates: Buy
Price Target: n/a
Current: $24.80
Upside: -
Amgen
Oct 21, 2024
Maintains: Buy
Price Target: $381 → $383
Current: $367.60
Upside: +4.19%
Nuvation Bio
Mar 8, 2021
Initiates: Outperform
Price Target: n/a
Current: $4.57
Upside: -
Regeneron Pharmaceuticals
Feb 8, 2021
Maintains: Outperform
Price Target: $684 → $565
Current: $764.93
Upside: -26.14%